Introduction
Cont inuous glucose monitoring in conjunction with a closed-loop insulin delivery could help in diabetes management and significantly reduce the risk of associated complications such as renal failure and blindness. 1 For this purpose, various glucose monitoring devices are being developed that can be classified as noninvasive, minimally invasive, and invasive. 2 Invasive devices based on subcutaneously implanted amperometric glucose sensors have received widespread scientific and commercial attention because of their simple operating principle and propensity to miniaturization. 2 First-generation Clark-based amperometric sensors employ a glucose oxidase (GO x ) enzyme immobilized on top of the working electrode (WE). 3, 4 The flavin adenine dinucleotide redox cofactor of GO x catalyzes the oxidation of glucose to glucarolactone, as shown in Equations (1) 
and (2):
Glucose + GO x (FAD) → Glucorolactone + GO x (FADH 2 )
(1)
The generated hydrogen peroxide (H 2 O 2) is amperometrically assessed on the surface of the WE in accordance with Equation (3):
The reliability of such subcutaneously implanted amperometric glucose sensors hinges on addressing the following interdependent factors: ), rendering Equation (2) oxygen limited. 4, 6 (ii) Suboptimal in vivo performance due to post-inflammation effects such as biofouling and foreign body response (FBR), leading to the formation of a fibrotic capsule that attenuates the diffusion of glucose and O 2 toward the WE. [8] [9] [10] [11] The extent of FBR is proportional to the magnitude of injury that occurred during device implantation, dependent on the size of the implantable sensor. 8, 12 The first issue is typically addressed via the use of glucose flux limiting [13] [14] [15] [16] [17] [18] [19] [20] [21] and/or O 2 -supplementing 21 membranes, while the latter concern is typically alleviated by employing biocompatible 12, [22] [23] [24] [25] [26] [27] [28] [29] [30] and/or inflammation-suppressing coatings. [31] [32] [33] [34] [35] [36] [37] [38] These approaches succeed at the expense of decreased sensitivity. 2, 4, 20, 29, 39 In order to minimize the injury inflicted during sensor implantation (that reduces the extent of FBR), device miniaturization also becomes important. 39, 40 Miniaturization, however, stands as another impediment for sensitivity, because reduction in the area of the WE generally leads to weaker signal intensity that approaches noise levels. To mitigate this challenge, biosensors have resorted to the use of high surface area nanostructured materials [e.g., mediators, nanotubes, metal nanoparticles (NPs)] along with appropriately engineered substrates. 39, [41] [42] [43] Toxicity concerns associated with the use of such nanostructured materials could ultimately hinder their application in implantable sensor configurations. 39 In addition, the need for high resilience against mechanical movement of the sensor in the dynamic in vivo environment restricts the design space to needle-implantable devices with high flexibility. 17, 20, 28, 29, 44, 45 In this article, we report on the fabrication and characterization of a needle-type glucose sensor that comfortably fits within a 26 G needle (with an inner diameter of 260 µm). Despite the reduction in the size of the WE, a robust in vivo and in vitro performance is demonstrated with sensor sensitivity and selectivity equivalent to or better than the currently reported needle-type sensors with larger surface areas. 17, 20, 28, 29, 44, 45 This has been achieved through electrochemical rebuilding of the gold WE, that together with platinum NPs and conformal layer engineering provided a 20-fold increase in electrocatalytic activity against H 2 O 2 detection. In vitro evaluation has shown that a glucose sensor utilizing such surface rebuilding showed a 4-5-fold increase in sensor response along with high selectivity (greater than 98%), high linearity (greater than 30 mM), and low response times (40 ± 6 s). In addition, short-term in vivo study in a rat model has shown that the glucose sensor reproducibly tracks the glycemic events, despite the large background noise in its microenvironment. Such high in vitro and in vivo performance together with adequate mechanical integrity and flexibility needed for long-term operation renders this "rebuilt" sensor promising for continuous glucose monitoring.
Experimental

Materials
Glucose oxidase enzyme, catalase, glutaraldehyde, phenol, bovine serum albumin, D-glucose, and Selectophore polyurethane (Tecoflex TM ) were purchased from Sigma. Poly(vinyl alcohol) (PVA; 99% hydrolyzed, molecular weight 133 kDa) was obtained from Polysciences Inc. Poly(lactic-co-glycolic acid) (PLGA) Resomer RG503H 50:50 was a gift from Boehringr-Ingelheim.
Experimental Methods
To prepare PVA solutions, 5% weight/volume aqueous solution of PVA was preheated to approximately 80°C to facilitate complete polymer dissolution.
Dexamethasone-loaded microspheres were prepared by an oil-in-water emulsion solvent extraction/evaporation technique as described previously. 33 Needle-type sensors were fabricated by coiling a 50 µm gold wire on top of a 125 µm platinum wire, which served as the WE. The starting surface area of the gold WE is approximately 0.18 mm 2 . The reference electrode was made by coiling a 50 µm silver wire in close proximity to the WE and converting its surface to silver chloride (AgCl) via galvanometry.
Surface rebuilding of the gold WE was achieved by immersing it in a 2 M sodium hydroxide solution and by applying a square wave potential waveform from -1.0 to +0.8 V versus Ag/AgCl. 46 Deposition of platinum NPs was achieved by immersing the rebuilt gold WE in 10 mM chloropatinic acid/0.1 M hydrogen chloride solution and by applying a bias of -0.05 V for 60 s. 47 For the fabrication of glucose sensors, the WE was sequentially coated with five different layers [namely, polyphenol (PPh), GO x , polyurethane, catalase, and PVA/PLGA composite] as reported before. 21, 33 Cyclic voltammetry (CV) was performed in a quiescent, oxygen-free solution of 10 mM potassium ferricyanide [K 3 Fe(CN) 6 ] in 0.1 potassium chloride (KCl) at a scan rate of 10 mV/s.
In vitro amperometric experiments were performed as reported earlier. 21, 33 In brief, the response of the sensor to either H 2 O 2 (or glucose) was obtained by applying a potential of 0.5 V to the WE and by raising the concentration from 0 to 0.5 mM and 2 to 35 mM for H 2 O 2 and glucose, respectively.
In vivo amperometric experiments were performed in young anesthetized male Sprague rats (150-175 g) as per Institutional Animal Care and Use Committee guidelines. The sensor is implanted into the subcutaneous (SC) tissue and is connected to a CHI workstation through two thin insulated wires that exit through the skin. The sensors were polarized for 2 h to obtain a stable signal, 28 following which 0.2 ml of sterile 50% dextrose was administered intraperitoneally. The response corresponding to the glycemic event of the rat was recorded continuously, while the tail-vein blood glucose readings were obtained periodically. Following the first glycemic event, a second glucose injection (0.4 ml of 50% dextrose) was administered, and the procedure was repeated again before proceeding to a third injection of 0.6 ml of 50% dextrose.
Results and Discussion
Sensitivity enhancement is a critical necessity for the higher noise levels typically encountered with in vivo biosensors. With this in mind, electrochemical surface rebuilding of gold was utilized to enhance surface area of the WE. 46 This converts the smooth surface of the WE to nanoporous morphology via the repeated etching and redeposition of the gold surface when subjected to a square waveform (at +0.8 and -1.0 V, at a frequency of 50 Hz for exposure times of 450 to 7200 s) in a 2 M sodium hydroxide solution. 46 During the application of the positive +0.8 V cycle, the gold surface gets oxidized, and the gold ions form a soluble complex with OH -, to be redeposited at the negative -1.0 V bias interval. The resulting nanoporous gold morphology is attained via templation by the oxygen and hydrogen microbubbles that are generated during the positive and negative potential cycles, respectively. 46 Cyclic voltammetry was used to assess the efficacy of the surface rebuilding process toward enhancing surface area of the gold WE. Typically, CV in a redox mediator [such as K 3 Fe(CN) 6 ] gives rise to anodic and cathodic peaks corresponding to the oxidation and reduction of the mediator. The intensity of the redox peak current is proportional to surface area, assuming that the electrocatalytic activity of the surface remains the same. Figure 1 shows the CV of the sensors before and after the surface rebuilding step, obtained in 10mM K 3 Fe(CN) 6 and 0.1M KCl at a scan rate of 50 mV/s. The well-defined anodic and cathodic waves, produced by the oxidation and reduction of K 3 Fe(CN) 6 , are retained following surface rebuilding of the gold WE. However, the intensity of the waves are substantially increased (by 9-10-fold), providing an initial indication of the enhancement in the surface area of the WE.
Effect of Etching Time
Having confirmed the utility of surface rebuilding toward increasing surface area, the effect of etching time has been investigated. For this sensor, sensitivity toward H 2 O 2 has been used as an assessment parameter since the electrooxidation of H 2 O 2 is the key step for the amperometric glucose sensing [Equations The H 2 O 2 sensitivity increased with increasing etching times and peaked at 15 min before dropping to a lower value and saturating at longer time periods. The peak sensitivity value is 20-fold higher when compared with the starting one. Such increase in sensor sensitivity is twice more than that recorded by the CV measurement in Figure 1 . This can be attributed to the smaller size of H 2 O 2 as compared with K 3 Fe(CN) 6 , which greatly improves the three-dimensional diffusion and analyte transfer to the nanoporous gold electrodes. 48 To further understand the origin in peak sensitivity observed at 15 min of electrochemical gold rebuilding, the nanoporous morphologies of the WE were assessed via scanning electron microscopy. Figure 3 depicts the surface morphology of the gold WE as a function of etching time. Here the following differences can be noted: (i) Among all electrochemical rebuilding times investigated, the 7.5 and 15 min etching times produced a "flowery" structure with an underlying nanoporous substructure (depicted with red arrows), both of which contribute to enhancement in surface area. Moreover, the underlying substructure for the 15 min etching time is more pronounced and porous compared with the 7.5 min etching time.
(ii) At etching times beyond 15 min, the outer "flowery" structure started to fuse together, disrupting the nanoscale morphology, and finally, at 120 min, most of the nanoscale features fused with each other, contributing to decrease in surface area.
These findings provide a visual understanding of the origin of peak sensitivity obtained at 15 min electrochemical rebuilding. Based on this, all further experiments were conducted using 15 min electrochemical rebuilding.
Further Improvement in Device Sensitivity Using Electrodeposited Platinum Nanoparticles
Even though the surface rebuilding via etching enhances the gold surface area, its utility toward sensor fabrication is hindered due to the inherent electrochemical instability of gold surfaces. 47, 48 For this, the rebuilt gold surface was further decorated with platinum NPs in accordance with Reference 48. The sensitivity increase afforded by the platinum NPs was investigated against electro-oxidation of H 2 O 2 . Figure 4 illustrates the H 2 O 2 sensitivity obtained for the same starting gold WE (0.569 mm 2 ) as a function of gold rebuilding and electrodeposition of platinum NPs. For the purpose of comparison, the sensitivities of two more configurations were investigated, namely, (i) bare gold and (ii) bare platinum, both of which were electrodeposited with platinum NPs. As illustrated in Figure 4 , surface rebuilding of gold electrodes followed by decoration with platinum NPs leads to sensitivity enhancement by nearly two orders of magnitude higher than bare gold electrodes. This implies that deposition of platinum NPs does not completely clog the pores created through surface rebuilding, in accordance with previous findings. 48 More importantly, the sensitivity of the platinum NP-decorated gold rebuilt electrode is twice as high as that of bare platinum decorated with platinum NPs, thus providing substantial cost reduction in starting materials.
Glucose Sensor Architecture
Having demonstrated a simplistic methodology to improve sensor sensitivity toward H 2 O 2 , the same has been used to realize a high-performance glucose sensor. For this, the rebuilt gold WE was decorated with platinum NPs and with various functional layers for reliable glucose detection. Figures 5A and 5B show a photograph and schematic cross section of the sensor. Figure 5C illustrates the various layers of the WE, whose function are described here:
(i) A conformal electropolymerized PPh layer (~10 nm) intended to prevent the diffusion of large molecular weight interferences (e.g., acetaminophen, ascorbic acid, uric acid) to the WE, where they are likely to get oxidized; 39 (ii) Glucose oxidase enzyme layer (20-25 µm) that was immobilized via glutaraldehyde cross linking;
(iii) A 1-2 µm polyurethane film intended to offset the large glucose-to-O 2 ratio within the SC tissue and improve sensor linearity; 39, 45, 49 (iv) A thin layer of catalase (5-10 µm) to convert H 2 O 2 to O 2 and enable facile extraction of H 2 O 2 from the GO x enzyme layer 19, 20, 45, 49, 50 (this provides a faster response time, minimal hysteresis, 20 excess O 2 to decrease the glucose-to-oxygen ratio, as well as preventing H 2 O 2 outer-diffusion to reduce irritation to the surrounding SC tissue); and (the PVA hydrogel provides a continuous pathway for diffusion of glucose toward the WE while the microspheres afford a controlled release of dexamethasone through PLGA degradation).
33,45,49
Glucose Sensor Characteristics
Sensor Response Time, Linearity, and Sensitivity Figure 6A illustrates the in vitro amperometric response of the fabricated glucose sensor to sequential additions of glucose. As evident, the sensor responded quickly and reproducibly to each of the glucose additions with a response time of 40 ± 8 s (time to achieve 90% of saturation current), similar to our earlier reports. 20 Figure 6B illustrates the saturation amperometric response versus glucose concentration, as obtained from the data of Figure 6A . Also shown in Figure 6B is the amperometric response versus glucose concentration curve for a control sensor that did undergo WE surface rebuilding but possessed platinum NPs as well as the five functional layers described earlier ( Figure 5C ). In both cases, the addition of glucose resulted in a linear increase of response for glucose concentrations as high as 30 mM, which is well beyond the physiological range. However, for any glucose concentration, the response of the "surface rebuilt" sensor is 4-5-fold higher than the control sensor, signifying the increase in surface area achieved through surface rebuilding. The in vitro glucose sensitivity of this "surface rebuilt" 26 G-fittable sensor as obtained from Figure 6B is 70 nA/mM/mm 2 . Table 1 compares the sensitivities obtained from the present work with those reported for similar "needle-type" glucose sensors. The sensitivity obtained from the present 26 G-fittable sensor is superior to previously reported ones (at least seven times better than sensors with the similar area). More importantly, it should be noted that such superior sensitivity has been obtained despite the presence of five functional layers as compared with three or four in previous reports. 20, 28, 29 This enhanced sensor sensitivity is primarily due to the surface rebuilding of the WE that substantially increases its surface area (see Figure 3) .
Sensor Selectivity
While the incorporation of PPh on top of WE has shown to be effective in block interferences at smoother WEs, 20 the same may not hold true for nanoporous WEs if this film is not conformal. This calls for a reinvestigation of the efficacy of PPh at nanoporous WE toward rejection of interferences. For this, we have chosen acetaminophen as a model interference substance, as it has been shown to be the most difficult one to be screened.
4 Figure 6C shows the response of sequential additions of 5 mM glucose and 0.1 mM acetaminophen when operated at 0.5 V. While the sensor shows a distinct and reproducible increase for glucose additions, negligible to no response is witnessed for acetaminophen additions (i.e., less than 2% of its amperometric response on bare platinum electrode; data not shown). This indicates that the electropolymerized PPh film affords uniform coating over gold rebuilt WE, which is decorated with platinum NPs. Moreover, such electropolymerized PPh film possesses similar porosity to that deposited on planar platinum surfaces, with pores sufficiently large to allow H 2 O 2 to pass through, yet small enough to prevent the diffusion of the larger sized acetaminophen. This also alludes to the fact that such PPh film also eliminates any direct oxidation of glucose on the highly electrocatalytic etched gold/platinum NPbased WE. 
In Vivo Glucose Sensor Performance Test
Reproducible operation in vivo presents the ultimate test for the functionality of any implantable glucose sensor. With this in mind, the in vivo performance of the glucose sensor was evaluated for a short period of time (3-4 h) in an unconscious (anesthetized) rat. Figure 7 shows the amperometric response from the SC implanted sensor for duration of approximately 4 h, along with the plasma glucose values determined from tail vein sampling. In response to an intraperitoneal injection of dextrose, the plasma glucose levels started to increase and peaked at around 10 min before coming back to normal levels. The sensor response closely tracked the plasma glucose levels. Similarly, in response to the subsequent second and third glucose injections, both the plasma glucose and sensor response showed a steady increase followed by a decrease. An average lag of approximately 5 ± 2 min (mean from the three glycemic peaks shown in Figure 7 ) was observed between the plasma glucose and the change in the sensor current. This lag phase is due to (i) the physical time lag between the interstitial fluid and plasma, which can vary between 4 and 10 min and (ii) the time needed for the sensor to reach saturation value following a change in the glucose concentration (i.e., the sensor response time). Considering the fact that in vitro sensor response time ( Figure 6A ) is only 40 s, it can be easily concluded that the lag phase observed in Figure 7 is due to physical lag time between the plasma and interstitial fluid glycemic events. 54 Overall, the short-term results of Figure 7 confirms the efficacy of the 26 G-fittable sensor to detect in vivo glycemic events and confirms its efficacy in tracking glycemic events in vivo despite a small WE and the presence of large background noises in its microenvironment. Currently, we are focused on evaluating the long-term (1 month) performance of this sensor in both in vitro and in vivo environments.
Conclusions
Electrochemical rebuilding of a gold WE produces a nano-porous morphology with enhanced surface area and results in a 20-fold increase in sensitivity toward H 2 O 2 detection. The inclusion of platinum NPs on top of the "rebuilt" WE further improves its H 2 O 2 sensitivity by another six-fold. The electropolymerization of phenol on top of such nanostructured electrode produces a thin, conformal, and pinhole-free layer of PPh that blocks redox interferences from interferences. Subsequent layering with GO x (for glucose sensing), polyurethane (for limiting glucose flux), catalase (for removing excess H 2 O 2 ), and PVA hydrogel/PLGA microspheres composite (for inflammation suppression) produces a highly reliable sensor with sensitivity as high as 70 nA/mM/cm 2 (4-5-fold increase in response when compared with a control sensor with nosurface rebuilding) and linearity up to 35 mM of glucose. Such a sensor is small enough to fit in a 26 G catheter and exhibits a six-fold higher sensitivity than previously reported needle-implantable devices. Short-term in vivo study has shown that the sensor can reproducibly track glycemic events despite the large background currents typically encountered during animal testing. Such performance proves that surface rebuilding of the WE can produce adequate sensitivity to afford device miniaturization as well as to bypass the need for mediators. Moreover, this approach is also amenable to a robust fabrication of miniaturized implantable glucose sensors.
